-
Je něco špatně v tomto záznamu ?
Precision in the design of an experimental study deflects the significance of proteinase-activated receptor 2 expression in scrapie-inoculated mice
Z. Hanusova, T. Mosko, R. Matej, K. Holada,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1967 do Před 1 rokem
Freely Accessible Science Journals
od 1967 do Před 12 měsíci
PubMed
28613153
DOI
10.1099/jgv.0.000803
Knihovny.cz E-zdroje
- MeSH
- modely nemocí na zvířatech MeSH
- myši knockoutované MeSH
- myši MeSH
- receptor PAR-2 nedostatek metabolismus MeSH
- scrapie patofyziologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Proteinase-activated receptor 2 (PAR2) is suspected to modulate the pathogenesis of various neurodegenerative conditions. We previously described delayed onset of clinical symptoms and prolonged survival of PAR2-deficient mice after intracerebral inoculation with prions. Here we report the results from a refined blinded study that aimed to investigate the effects of PAR2 deletion on scrapie pathogenesis after peripheral infection. This study failed to confirm that PAR2 deficiency impacts on the length of the incubation period, with PAR2-/- and PAR2+/+ littermates developing scrapie at the same time. To clarify the discrepancy between the two observations, we repeated the intracerebral inoculation study while utilizing our refined protocol, which aimed to limit possible sources of experimental bias. The study again failed to confirm the significant effect of PAR2 expression on the course of prion infection. Our report emphasizes and discusses the importance of unbiased experimental design and the selection of proper genetic controls when using genetically altered animal models for prion pathogenesis studies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030738
- 003
- CZ-PrNML
- 005
- 20171027104657.0
- 007
- ta
- 008
- 171025s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1099/jgv.0.000803 $2 doi
- 035 __
- $a (PubMed)28613153
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hanusova, Zdenka $u 1Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, Prague 2, 128 00, Czech Republic.
- 245 10
- $a Precision in the design of an experimental study deflects the significance of proteinase-activated receptor 2 expression in scrapie-inoculated mice / $c Z. Hanusova, T. Mosko, R. Matej, K. Holada,
- 520 9_
- $a Proteinase-activated receptor 2 (PAR2) is suspected to modulate the pathogenesis of various neurodegenerative conditions. We previously described delayed onset of clinical symptoms and prolonged survival of PAR2-deficient mice after intracerebral inoculation with prions. Here we report the results from a refined blinded study that aimed to investigate the effects of PAR2 deletion on scrapie pathogenesis after peripheral infection. This study failed to confirm that PAR2 deficiency impacts on the length of the incubation period, with PAR2-/- and PAR2+/+ littermates developing scrapie at the same time. To clarify the discrepancy between the two observations, we repeated the intracerebral inoculation study while utilizing our refined protocol, which aimed to limit possible sources of experimental bias. The study again failed to confirm the significant effect of PAR2 expression on the course of prion infection. Our report emphasizes and discusses the importance of unbiased experimental design and the selection of proper genetic controls when using genetically altered animal models for prion pathogenesis studies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a receptor PAR-2 $x nedostatek $x metabolismus $7 D044464
- 650 _2
- $a scrapie $x patofyziologie $7 D012608
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mosko, Tibor $u 1Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, Prague 2, 128 00, Czech Republic.
- 700 1_
- $a Matej, Radoslav $u 2Department of Pathology and Molecular Medicine, Thomayer Teaching Hospital, Videnska 800, Prague 4, 14059, Czech Republic 3Department of Pathology, First Faculty of Medicine, Charles University, Studnickova 2, Prague 2, 12800, Czech Republic.
- 700 1_
- $a Holada, Karel $u 1Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, Prague 2, 128 00, Czech Republic.
- 773 0_
- $w MED00002692 $t The Journal of general virology $x 1465-2099 $g Roč. 98, č. 6 (2017), s. 1563-1569
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28613153 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171027104742 $b ABA008
- 999 __
- $a ok $b bmc $g 1254331 $s 991765
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 98 $c 6 $d 1563-1569 $e 20170614 $i 1465-2099 $m Journal of general virology $n J Gen Virol $x MED00002692
- LZP __
- $a Pubmed-20171025